Literature DB >> 23603377

Adrenal vein sampling: substantial need for technical improvement at regional referral centres.

Panda Elliott1, Daniel T Holmes.   

Abstract

OBJECT: Adrenal vein sampling (AVS) is the gold standard for localization of aldosterone producing adenoma. The anatomy of the right adrenal vein makes this procedure technically demanding and it may yield no clinical information if the adrenal veins are not adequately cannulated. Having frequently observed the technical failure of AVS, we undertook a review of 220 procedures in British Columbia, Canada. DESIGN AND METHODS: Subjects were retrospectively identified through the laboratory information system. The following were collected: demographics, screening aldosterone concentration and renin activity/mass, results of dynamic function tests, AVS aldosterone and cortisol results. Standard calculations were performed on AVS data and site-specific success rates were compared. The effect of adrenocorticotropin hormone (ACTH) stimulation on the selectivity index (SI) and lateralization index (LI) were explored.
RESULTS: The overall technical success-rate of AVS procedures was only 44% in procedures where no ACTH-stimulation was used (n=200) but this rose significantly (p<0.01) to 82% for those employing ACTH (n=139). ACTH-stimulation significantly increased the median SI (left: 5.8 vs 36.7, p<0.01; right: 7.0 vs 51.2, p<0.01), and salvaged 36 procedures from yielding no information, 21 of which demonstrated lateralization of aldosterone production. In 64 cases showing lateralization both pre and post-stimulation, ACTH significantly decreased the median LI from 5.4 to 2.2, p<0.01, creating substantial risk for spurious loss of lateralization.
CONCLUSIONS: The technical success of AVS is lower than reported elsewhere. Provided that effects on the LI are considered, the use of ACTH-stimulation during AVS assists in the identification of unilateral forms of PA.
Copyright © 2013 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ACTH; APA; AVS; Adrenal Vein Sampling; Adrenal hypertension; Adrenal vein sampling; Adrenocorticotropin Hormone; Aldosterone Producing Adenoma; BAH; BC; Bilateral Adrenal Hyperplasia; British Columbia; Conn's syndrome; IVC; Inferior Vena Cava; LAV; LI; LL; Lateralization Index; Left Adrenal Vein; LifeLabs; Mineralocorticoid; PA; PRA; PRM; Plasma Renin Activity; Plasma Renin Mass; Primary Aldosteronism; Primary aldosteronism; RAV; Right Adrenal Vein; SAC; SI; SPH; Selectivity Index; Serum Aldosterone Concentration; St. Paul's Hospital

Mesh:

Substances:

Year:  2013        PMID: 23603377     DOI: 10.1016/j.clinbiochem.2013.04.004

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  5 in total

1.  Despite limited specificity, computed tomography predicts lateralization and clinical outcome in primary aldosteronism.

Authors:  G A Kline; V C Dias; B So; A Harvey; J L Pasieka
Journal:  World J Surg       Date:  2014-11       Impact factor: 3.352

2.  Visualization of the right adrenal vein using CT during right inferior phrenic arteriography in hepatocellular carcinoma patients.

Authors:  Sota Oguro; Seishi Nakatsuka; Masahiro Jinzaki; Manabu Misu; Hideki Yashiro; Subaru Hashimoto; Sachio Kuribayashi
Journal:  Jpn J Radiol       Date:  2014-09-24       Impact factor: 2.374

3.  Three Discrete Patterns of Primary Aldosteronism Lateralization in Response to Cosyntropin During Adrenal Vein Sampling.

Authors:  Taweesak Wannachalee; Lili Zhao; Kazutaka Nanba; Aya T Nanba; James J Shields; William E Rainey; Richard J Auchus; Adina F Turcu
Journal:  J Clin Endocrinol Metab       Date:  2019-12-01       Impact factor: 5.958

4.  Approach to the Patient with Primary Aldosteronism: Utility and Limitations of Adrenal Vein Sampling.

Authors:  Adina F Turcu; Richard Auchus
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 5.958

5.  A clinical prediction score for diagnosing unilateral primary aldosteronism may not be generalizable.

Authors:  Erik S Venos; Benny So; Valerian C Dias; Adrian Harvey; Janice L Pasieka; Gregory A Kline
Journal:  BMC Endocr Disord       Date:  2014-12-11       Impact factor: 2.763

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.